PAR — Par Drugs and Chemicals Income Statement
0.000.00%
Last trade - 00:00
- IN₹2.95bn
- IN₹2.58bn
- IN₹956.40m
- 98
- 36
- 65
- 79
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | IAS | — | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 558 | 608 | 751 | 957 | 956 |
Cost of Revenue | |||||
Gross Profit | 162 | 389 | 463 | 293 | 618 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 492 | 456 | 621 | 808 | 763 |
Operating Profit | 66.9 | 152 | 130 | 150 | 194 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 59.9 | 147 | 127 | 151 | 195 |
Provision for Income Taxes | |||||
Net Income After Taxes | 47.6 | 116 | 92.1 | 113 | 145 |
Net Income Before Extraordinary Items | |||||
Net Income | 47.6 | 116 | 92.1 | 113 | 145 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 47.6 | 116 | 92.1 | 113 | 145 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.72 | 16.3 | 7.49 | 9.12 | 11.8 |
Dividends per Share |